Canada needs to plan for inevitable future pandemics
Dec 30, 2022 - Despite the continuing emergence of new variants and outbreaks of COVID-19, the current pandemic is starting to recede from many Canadians’ minds.
VIDO’s economic impact over half a billion dollars: SREDA study
Dec 19, 2022 - The Saskatoon Regional Economic Development Authority's Economic Impact Study concluded VIDO’s operations and construction projects contributed more than $511 million to the economy in the last decade.
VIDO part of western Canadian team developing tools to stop chronic wasting disease
Dec 7, 2022 - Drs. Scott Napper, Philip Griebel and Suresh Tikoo are part of a western Canadian multidisciplinary team awarded a $4.25 million NSERC Alliance Grant to develop mitigation strategies for chronic wasting disease.
New $8.1 million funding for VIDO will protect Canadians and our animals from high consequence pathogens
Nov 16, 2022 - VIDO has received a significant investment from the Canada Foundation for Innovation to establish containment Level 4 capacity—the highest level of containment. Once completed, this will make VIDO the only non-government CL4 facility in Canada.
Individual donors vital for VIDO to become Canada’s Centre for Pandemic Research
Nov 6, 2022 - VIDO is one of our province’s most outstanding success stories. An important part of its future is now up to us.
Research team aims to develop vaccines for prion diseases
Sep 20, 2022 - Even Dr. Scott Napper uses words such as scary when describing the focus of his research—a group of diseases caused when otherwise innocuous proteins go rogue, creating conditions that are always fatal and currently untreatable.
Researchers’ study of Salmonella transmission first of its kind
Sep 19, 2022 - Dr. Aaron White and his team recently received a Natural Sciences and Engineering Research Council of Canada Discovery Grant to get to the heart — or the gut — of how and why Salmonella bacteria continue to thrive.
CEPI: The Race to Future-Proof Coronavirus Vaccines
Sep 8, 2022 - "What we’re striving for is something that can be broadly protective not only against what’s circulating now, but also in the future as the virus mutates."
New support for VIDO as a research facility of national importance
Aug 20, 2022 - The benefit of VIDO’s cutting-edge infrastructure has been acknowledged through funding from the Canada Foundation for Innovation Major Science Initiatives Fund.
VIDO: Advancing human, animal health at home and abroad
Jul 14, 2022 - VIDO is committed to protecting Canada and the world from infectious diseases, in both animals and humans. Approximately 70 per cent of the pathogens that affect humans come from animals.
New VIDO Vaccine Development Centre supports vaccine innovation protecting Canadians, animals
Jun 28, 2022 - USask's Vaccine and Infectious Disease Organization has completed the construction of its Vaccine Development Centre, strengthening and expanding Canada’s domestic biomanufacturing capacity.
VIDO: Saskatchewan’s gift to global health
Jun 3, 2022 - The opening of its new Vaccine Development Centre advances VIDO’s position as Canada’s Centre for Pandemic Research.
USask hosts the Prime Minister of Canada
May 25, 2022 - Prime Minister Justin Trudeau paid tribute to the contributions the University of Saskatchewan has made to scientific discovery, as he wrapped up his visit to campus on Wednesday.
A new opportunity to develop livestock and human vaccine in Saskatchewan: SARM supports VIDO‘s effort to strengthen the response to infectious disease
Mar 3, 2022 - The Saskatchewan Association of Rural Municipalities Board of Director’s met with VIDO in January, to discuss the ways rural municipalities can support and strengthen the world’s response to infectious diseases.
Developing oral vaccine for chronic wasting disease goal of funding research
Jan 24, 2022 - Prion disease poses significant risk to wildlife, but research into developing vaccine cause for optimism.
Investments in USask livestock research fuels innovation, protects animal health
Jan 19, 2022 - University of Saskatchewan (USask) researchers have been awarded $4.2 million to develop livestock-related innovations that range from improving forage feed to advancing work on vaccines to tackle the global spread of African swine fever (ASF).